J.P. Sculier
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
Papers in
-
- Lung Cancer Diagnosis and Treatment 21
- Lung Cancer Treatments and Mutations 1
- Oncology 13
- Lung Cancer Research Studies 11
- Co-authors
- Peter Goldstraw (2 shared papers)Jan P. van Meerbeeck (1 shared paper)Dori Giroux (1 shared paper)Kari Chansky (1 shared paper)John J. Crowley (1 shared paper)Marianne Paesmans (20 shared papers)Jean‐Jacques Lafitte (14 shared papers)Céline Mascaux (9 shared papers)
In The Last Decade
J.P. Sculier
50 papers receiving 2.1k citations
J.P. Sculier's Hit Papers
Peers
Comparison fields: 5 of 59
- Infectious Diseases 601
- Pulmonary and Respiratory Medicine 605
- Oncology 131
- Health, Toxicology and Mutagenesis 58
- Atmospheric Science 51
Countries citing papers authored by J.P. Sculier
This map shows the geographic impact of J.P. Sculier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Sculier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Sculier more than expected).
Fields of papers citing papers by J.P. Sculier
This network shows the impact of papers produced by J.P. Sculier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Sculier. The network helps show where J.P. Sculier may publish in the future.
Co-authors
The 25 scholars most cited alongside J.P. Sculier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Towards tuberculosis elimination: an action framework for low-incidence countries Hit paper breakdown → | 2015 | 644 |
| 2 | 2009 | 394 | |
| 3 | 2015 | 204 | |
| 4 | 2005 | 161 | |
| 5 | 2006 | 120 | |
| 6 | 1990 | 53 | |
| 7 | 2013 | 51 | |
| 8 | 1987 | 50 | |
| 9 | 2004 | 49 | |
| 10 | 2000 | 43 | |
| 11 | 2011 | 42 | |
| 12 | 2008 | 38 | |
| 13 | 2003 | 33 | |
| 14 | 2015 | 31 | |
| 15 | 1985 | 29 | |
| 16 | 1988 | 24 | |
| 17 | 1999 | 23 | |
| 18 | 2005 | 22 | |
| 19 | 1989 | 18 | |
| 20 | 2003 | 18 |
About J.P. Sculier
J.P. Sculier is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Infectious Diseases, Cardiology and Cardiovascular Medicine and Statistics, Probability and Uncertainty, having authored 56 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (21 papers), Lung Cancer Research Studies (11 papers), Antifungal resistance and susceptibility (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Lung Cancer Treatments and Mutations (1 paper), Innovations in Medical Education (1 paper), Sepsis Diagnosis and Treatment (1 paper) and Pericarditis and Cardiac Tamponade (1 paper). The work is most often cited by research in Infectious Diseases (601 citations), Pulmonary and Respiratory Medicine (605 citations), Oncology (131 citations), Health, Toxicology and Mutagenesis (58 citations) and Atmospheric Science (51 citations). J.P. Sculier has collaborated with scholars based in Belgium, France and Canada. Frequent co-authors include Peter Goldstraw, Jan P. van Meerbeeck, Dori Giroux, Kari Chansky, John J. Crowley, Marianne Paesmans, Jean‐Jacques Lafitte, Céline Mascaux, A.-P. Meert and Th. Berghmans. Their work appears in journals such as Lung Cancer, European Journal of Cancer, European Respiratory Journal, Annals of Oncology and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.